Cargando…

Limosilactobacillus fermentum CECT5716: Mechanisms and Therapeutic Insights

Probiotics microorganisms exert their health-associated activities through some of the following general actions: competitive exclusion, enhancement of intestinal barrier function, production of bacteriocins, improvement of altered microbiota, and modulation of the immune response. Among them, Limos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez-Sojo, María Jesús, Ruiz-Malagón, Antonio Jesús, Rodríguez-Cabezas, María Elena, Gálvez, Julio, Rodríguez-Nogales, Alba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003974/ https://www.ncbi.nlm.nih.gov/pubmed/33801082 http://dx.doi.org/10.3390/nu13031016

Ejemplares similares

Beneficial Effects of Limosilactobacillus fermentum CECT 5716 Administration to Infants Delivered by Cesarean Section
por: Blanco-Rojo, Ruth, et al.
Publicado: (2022)

Beneficial Effects of Limosilactobacillus fermentum in the DCA Experimental Model of Irritable Bowel Syndrome in Rats
por: Rodríguez-Sojo, María Jesús, et al.
Publicado: (2022)

Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk
por: Ozen, Metehan, et al.
Publicado: (2023)

Evaluation of the Effect of Limosilactobacillus fermentum CECT5716 on Gastrointestinal Infections in Infants: A Systematic Review and Meta-Analysis
por: Pastor-Villaescusa, Belén, et al.
Publicado: (2021)

Lactobacillus fermentum CECT5716 Supplementation in Rats during Pregnancy and Lactation Impacts Maternal and Offspring Lipid Profile, Immune System and Microbiota
por: Azagra-Boronat, Ignasi, et al.
Publicado: (2020)

Lactobacillus fermentum CECT5716 Alleviates the Inflammatory Response in Asthma by Regulating TLR2/TLR4 Expression
por: Wang, Weifang, et al.
Publicado: (2022)

Oral Administration to Nursing Women of Lactobacillus fermentum CECT5716 Prevents Lactational Mastitis Development: A Randomized Controlled Trial
por: Hurtado, José A., et al.
Publicado: (2017)

Study protocol: evaluation of the probiotic Lactobacillus Fermentum CECT5716 for the prevention of mastitis in breastfeeding women: a randomised controlled trial
por: Bond, Diana M., et al.
Publicado: (2017)

Intestinal anti-inflammatory and visceral analgesic effects of a Serpylli herba extract in an experimental model of irritable bowel syndrome in rats
por: Ruiz-Malagón, Antonio Jesús, et al.
Publicado: (2022)

Oral Lactobacillus fermentum CECT5716 in the patients with lactational abscess treated by needle aspiration: The late follow-up of a randomized controlled trial
por: Zhang, Yi, et al.
Publicado: (2022)

Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial
por: Maldonado, J., et al.
Publicado: (2019)

In Vitro Antitumor and Anti-Inflammatory Activities of Allium-Derived Compounds Propyl Propane Thiosulfonate (PTSO) and Propyl Propane Thiosulfinate (PTS)
por: Guillamón, Enrique, et al.
Publicado: (2023)

The Antioxidant Activity of Thymus serpyllum Extract Protects against the Inflammatory State and Modulates Gut Dysbiosis in Diet-Induced Obesity in Mice
por: Ruiz-Malagón, Antonio Jesús, et al.
Publicado: (2022)

An Overview of the Use and Applications of Limosilactobacillus fermentum in Broiler Chickens
por: Racines, Maria Paula, et al.
Publicado: (2023)

Probiotic and Functional Properties of Limosilactobacillus reuteri INIA P572
por: Diez-Echave, Patricia, et al.
Publicado: (2021)

Lactobacillus fermentum CECT 5716 and a reduction of the Staphylococcus load in breast milk which reduces the risk of infectious mastitis: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
por: Turck, Dominique, et al.
Publicado: (2017)

Complete Annotated Genome Sequence of Limosilactobacillus fermentum AGR1487
por: Bailie, Marc A., et al.
Publicado: (2021)

Limosilactobacillus fermentum Limits Candida glabrata Growth by Ergosterol Depletion
por: Zangl, Isabella, et al.
Publicado: (2023)

The Antioxidant Properties of Lavandula multifida Extract Contribute to Its Beneficial Effects in High-Fat Diet-Induced Obesity in Mice
por: Molina-Tijeras, Jose Alberto, et al.
Publicado: (2023)

Metabolomics Analysis for Nitrite Degradation by the Metabolites of Limosilactobacillus fermentum RC4
por: Xia, Chaoran, et al.
Publicado: (2022)

Characteristics and Whole-Genome Analysis of Limosilactobacillus fermentum Phage LFP02
por: Lv, Ruirui, et al.
Publicado: (2023)

Soluble peptidoglycan fragments produced by Limosilactobacillus fermentum with antiproliferative activity are suitable for potential therapeutic development: A preliminary report
por: Fuochi, Virginia, et al.
Publicado: (2023)

Targeting gut microbiome, is it always a therapeutic option?
por: Rodríguez-Nogales, Alba, et al.
Publicado: (2020)

Determination of Antiviral Mechanism of Centenarian Gut-Derived Limosilactobacillus fermentum Against Norovirus
por: Li, Ying, et al.
Publicado: (2022)

Probiotic effects of Lacticaseibacillus rhamnosus 1155 and Limosilactobacillus fermentum 2644 on hyperuricemic rats
por: Li, Yanjun, et al.
Publicado: (2022)

Immune-Enhancing Effects of Limosilactobacillus fermentum in BALB/c Mice Immunosuppressed by Cyclophosphamide
por: Kim, SukJin, et al.
Publicado: (2023)

Metabolites Potentially Determine the High Antioxidant Properties of Limosilactobacillus fermentum U-21
por: Grishina, Yelena V., et al.
Publicado: (2023)

The Prebiotic Effects of an Extract with Antioxidant Properties from Morus alba L. Contribute to Ameliorate High-Fat Diet-Induced Obesity in Mice
por: Rodríguez-Sojo, María Jesús, et al.
Publicado: (2023)

Flavonoids in Inflammatory Bowel Disease: A Review
por: Vezza, Teresa, et al.
Publicado: (2016)

Genome analysis of Limosilactobacillus fermentum JN2019 applied to tumeric fermentation for animal feed
por: Yoo, Heeseop, et al.
Publicado: (2021)

Limosilactobacillus fermentum MG4295 Improves Hyperglycemia in High-Fat Diet-Induced Mice
por: Kim, Ji Eun, et al.
Publicado: (2022)

Exploration of the Molecular Mechanisms Underlying the Anti-Photoaging Effect of Limosilactobacillus fermentum XJC60
por: Chen, Huizhen, et al.
Publicado: (2022)

Potential role of Limosilactobacillus fermentum as a probiotic with anti-diabetic properties: A review
por: Lacerda, Diego Cabral, et al.
Publicado: (2022)

Limosilactobacillus fermentum JL-3 isolated from “Jiangshui” ameliorates hyperuricemia by degrading uric acid
por: Wu, Ying, et al.
Publicado: (2021)

Synergistic Effects of Limosilactobacillus fermentum ASBT-2 with Oxyresveratrol Isolated from Coconut Shell Waste
por: Prakash, Vidhya, et al.
Publicado: (2021)

Protective effect of Limosilactobacillus fermentum HFY06 on dextran sulfate sodium-induced colitis in mice
por: Liu, Bihui, et al.
Publicado: (2022)

In Vitro Characterization of Probiotic Potential of Limosilactobacillus fermentum against Salmonella Gallinarum Causing Fowl Typhoid
por: Mehmood, Adnan, et al.
Publicado: (2023)

Formulation of food grade Limosilactobacillus fermentum for antifungal properties isolated from home-made curd
por: Mandal, Sucheta, et al.
Publicado: (2023)

Safety and efficacy of a feed additive consisting on Lactiplantibacillus plantarum (formerly Lactobacillus plantarum) CECT 8350 and Limosilactobacillus reuteri (formerly Lactobacillus reuteri) CECT 8700 (AQ02) for suckling piglets (AQUILON CYL S.L.)
por: Bampidis, Vasileios, et al.
Publicado: (2021)

Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review
por: Algieri, Francesca, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cb4mdnbrdbb4ojc6jskof4v82u